The Functional Proximal Proteome of Oncogenic Ras Includes mTORC2

Fiji: an open-source platform for biological-image analysis

Schindelin, J., Arganda-Carreras, I., Frise, E., Kaynig, V., Longair, M., Pietzsch, T., Preibisch, S., Rueden, C., Saalfeld, S., Schmid, B., et al. (2012) · Nature Methods · doi:10.1038/nmeth.2019 · Cited by 66,890 · see citing works

Ultrafast and memory-efficient alignment of short DNA sequences to the human genome.

Langmead, B., Trapnell, C., Pop, M., & Salzberg, S. L. (2009) · Genome Biology · doi:10.1186/gb-2009-10-3-r25 · Cited by 21,849 · see citing works

TopHat2: accurate alignment of transcriptomes in the presence of insertions, deletions and gene fusions.

Kim, D., Pertea, G., Trapnell, C., Pimentel, H., Kelley, R., & Salzberg, S. L. (2013) · Genome Biology · doi:10.1186/gb-2013-14-4-r36 · Cited by 12,668 · see citing works

STRING v10: protein–protein interaction networks, integrated over the tree of life

Szklarczyk, D., Franceschini, A., Wyder, S., Forslund, K., Heller, D., Huerta-Cepas, J., Simonovic, M., Roth, A., Santos, A., Tsafou, K. P., et al. (2015) · Nucleic Acids Research · doi:10.1093/nar/gku1003 · Cited by 10,436 · see citing works

mTOR Signaling in Growth Control and Disease

Laplante, M., & Sabatini, D. M. (2012) · Cell · doi:10.1016/j.cell.2012.03.017 · Cited by 8,509 · see citing works

Enrichr: interactive and collaborative HTML5 gene list enrichment analysis tool

Chen, E. Y., Tan, C. M., Kou, Y., Duan, Q., Wang, Z., Meirelles, G. V., Clark, N. R., & Ma’ayan, A. (2013) · BMC Bioinformatics · doi:10.1186/1471-2105-14-128 · Cited by 7,814 · see citing works

Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex

Sarbassov, D. D., Guertin, D. A., Ali, S. M., & Sabatini, D. M. (2005) · Science · doi:10.1126/science.1106148 · Cited by 6,216 · see citing works

Improved vectors and genome-wide libraries for CRISPR screening

Sanjana, N. E., Shalem, O., & Zhang, F. (2014) · Nature Methods · doi:10.1038/nmeth.3047 · Cited by 5,239 · see citing works

In-gel digestion for mass spectrometric characterization of proteins and proteomes

Shevchenko, A., Tomas, H., Havli, J., Olsen, J. V., & Mann, M. (2006) · Nature Protocols · doi:10.1038/nprot.2006.468 · Cited by 4,867 · see citing works

Target-decoy search strategy for increased confidence in large-scale protein identifications by mass spectrometry

Elias, J. E., & Gygi, S. P. (2007) · Nature Methods · doi:10.1038/nmeth1019 · Cited by 3,925 · see citing works

Differential analysis of gene regulation at transcript resolution with RNA-seq

Trapnell, C., Hendrickson, D. G., Sauvageau, M., Goff, L., Rinn, J. L., & Pachter, L. (2013) · Nature Biotechnology · doi:10.1038/nbt.2450 · Cited by 3,492 · see citing works

Defining the role of mTOR in cancer

Guertin, D. A., & Sabatini, D. M. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.05.008 · Cited by 2,833 · see citing works

MAGeCK enables robust identification of essential genes from genome-scale CRISPR/Cas9 knockout screens

Li, W., Xu, H., Xiao, T., Cong, L., Love, M. I., Zhang, F., Irizarry, R. A., Liu, J. S., Brown, M., & Liu, X. S. (2014) · Genome Biology · doi:10.1186/s13059-014-0554-4 · Cited by 2,684 · see citing works

A promiscuous biotin ligase fusion protein identifies proximal and interacting proteins in mammalian cells

Roux, K. J., Kim, D. I., Raida, M., & Burke, B. (2012) · Journal of Cell Biology · doi:10.1083/jcb.201112098 · Cited by 2,416 · see citing works

A Comprehensive Survey of Ras Mutations in Cancer

Prior, I. A., Lewis, P. D., & Mattos, C. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-2612 · Cited by 2,063 · see citing works

Dynamic Imaging of Genomic Loci in Living Human Cells by an Optimized CRISPR/Cas System

Chen, B., Gilbert, L. A., Cimini, B. A., Schnitzbauer, J., Zhang, W., Li, G., Park, J. S., Blackburn, E. H., Weissman, J. S., Qi, L. S., et al. (2013) · Cell · doi:10.1016/j.cell.2013.12.001 · Cited by 1,931 · see citing works

RAS oncogenes: weaving a tumorigenic web

Pylayeva-Gupta, Y., Grabocka, E., & Bar-Sagi, D. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3106 · Cited by 1,789 · see citing works

Ras oncogenes: split personalities

Karnoub, A. E., & Weinberg, R. A. (2008) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2438 · Cited by 1,467 · see citing works

Rheb Binds and Regulates the mTOR Kinase

Long, X., Lin, Y., Ortiz-Vega, S., Yonezawa, K., & Avruch, J. (2005) · Current Biology · doi:10.1016/j.cub.2005.02.053 · Cited by 1,005 · see citing works

mTOR complex 2 (mTORC2) controls hydrophobic motif phosphorylation and activation of serum- and glucocorticoid-induced protein kinase 1 (SGK1)

García-Martínez, J. M., & Alessi, D. R. (2008) · Biochemical Journal · doi:10.1042/bj20081668 · Cited by 907 · see citing works

SAINT: probabilistic scoring of affinity purification–mass spectrometry data

Choi, H., Larsen, B., Lin, Z.-Y., Breitkreutz, A., Mellacheruvu, D., Fermin, D., Qin, Z. S., Tyers, M., Gingras, A.-C., & Nesvizhskii, A. I. (2011) · Nature Methods · doi:10.1038/nmeth.1541 · Cited by 800 · see citing works

Dragging ras back in the ring

Stephen, A. G., Esposito, D., Bagni, R. K., & McCormick, F. (2014) · Cancer Cell · doi:10.1016/j.ccr.2014.02.017 · Cited by 795 · see citing works

Selective inhibition of oncogenic KRAS output with small molecules targeting the inactive state

Patricelli, M. P., Janes, M. R., Li, L.-S., Hansen, R., Peters, U., Kessler, L. V., Chen, Y., Kucharski, J. M., Feng, J., Ely, T., et al. (2016) · Cancer Discovery · doi:10.1158/2159-8290.cd-15-1105 · Cited by 759 · see citing works

The E2F transcriptional network: old acquaintances with new faces

Dimova, D. K., & Dyson, N. J. (2005) · Oncogene · doi:10.1038/sj.onc.1208612 · Cited by 715 · see citing works

Gene Essentiality Profiling Reveals Gene Networks and Synthetic Lethal Interactions with Oncogenic Ras

Wang, T., Yu, H., Hughes, N. W., Liu, B., Kendirli, A., Klein, K., Chen, W. W., Lander, E. S., & Sabatini, D. M. (2017) · Cell · doi:10.1016/j.cell.2017.01.013 · Cited by 632 · see citing works

Crystal Structure and Functional Analysis of Ras Binding to Its Effector Phosphoinositide 3-Kinase γ

Pacold, M. E., Suire, S., Perišić, O., Lara‐González, S., Davis, C. T., Walker, E. H., Hawkins, P. T., Stephens, L., Eccleston, J. F., & Williams, R. L. (2000) · Cell · doi:10.1016/s0092-8674(00)00196-3 · Cited by 603 · see citing works

Activation of phosphoinositide 3‐kinase by interaction with Ras and by point mutation.

Rodriguez‐Viciana, P., Warne, P. H., Vanhaesebroeck, B., Waterfield, M. D., & Downward, J. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00602.x · Cited by 565 · see citing works

mTOR complex 2 signaling and functions

Oh, W. J., & Jacinto, E. (2011) · Cell Cycle · doi:10.4161/cc.10.14.16586 · Cited by 561 · see citing works

Mechanisms of mTORC1 activation by RHEB and inhibition by PRAS40

Yang, H., Jiang, X., Li, B., Yang, H. J., Miller, M., Yang, A., Dhar, A., & Pavletich, N. P. (2017) · Nature · doi:10.1038/nature25023 · Cited by 548 · see citing works

BioID: A Screen for Protein‐Protein Interactions

Roux, K. J., Kim, D. I., & Burke, B. E. (2013) · Current Protocols in Protein Science · doi:10.1002/0471140864.ps1923s74 · Cited by 505 · see citing works

Structural insights into phosphoinositide 3-kinase catalysis and signalling

Walker, E. H., Perišić, O., Ried, C., Stephens, L., & Williams, R. L. (1999) · Nature · doi:10.1038/46319 · Cited by 501 · see citing works

mTORC1 and mTORC2 in cancer and the tumor microenvironment

Kim, L. C., Cook, R. S., & Chen, J. (2016) · Oncogene · doi:10.1038/onc.2016.363 · Cited by 443 · see citing works

Drugging RAS: know the enemy

Papke, B., & Der, C. J. (2017) · Science · doi:10.1126/science.aam7622 · Cited by 399 · see citing works

PtdIns(3,4,5) P 3-Dependent Activation of the mTORC2 Kinase Complex

Liu, P., Gan, W., Chin, Y. R., Ogura, K., Guo, J., Zhang, J., Wang, B., Blenis, J., Cantley, L. C., Toker, A., et al. (2015) · Cancer Discovery · doi:10.1158/2159-8290.cd-15-0460 · Cited by 385 · see citing works

KRAS Alleles: The Devil Is in the Detail

Haigis, K. M. (2017) · Trends in Cancer · doi:10.1016/j.trecan.2017.08.006 · Cited by 373 · see citing works

Oncogenic Ras Activation of Raf/Mitogen-Activated Protein Kinase-Independent Pathways Is Sufficient To Cause Tumorigenic Transformation

Khosravi‐Far, R., White, M. A., Westwick, J. K., Solski, P. A., Chrzanowska‐Wodnicka, M., Aelst, L. V., Wigler, M. H., & Der, C. J. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.7.3923 · Cited by 343 · see citing works

Therapeutic Strategies for Targeting Ras Proteins

Gysin, S., Salt, M. B., Young, A. E., & McCormick, F. (2011) · Genes & Cancer · doi:10.1177/1947601911412376 · Cited by 321 · see citing works

Filling the Void: Proximity-Based Labeling of Proteins in Living Cells

Kim, D. I., & Roux, K. J. (2016) · Trends in Cell Biology · doi:10.1016/j.tcb.2016.09.004 · Cited by 288 · see citing works

Ras-GTP dimers activate the Mitogen-Activated Protein Kinase (MAPK) pathway

Nan, X., Tamgüney, T. M., Collisson, E. A., Lin, L.-J., Pitt, C., Galeas, J., Lewis, S., Gray, J. W., McCormick, F., & Chu, S. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1509123112 · Cited by 273 · see citing works

K-Ras promotes tumorigenicity through suppression of non-canonical Wnt signaling

Wang, M.-T., Holderfield, M., Galeas, J., Delrosario, R., To, M. D., Balmain, A., & McCormick, F. (2015) · Cell · doi:10.1016/j.cell.2015.10.041 · Cited by 196 · see citing works

The AGC kinase SGK1 regulates TH1 and TH2 differentiation downstream of the mTORC2 complex

Heikamp, E., Patel, C. H., Collins, S., Waickman, A. T., Oh, M. H., Sun, I., Illei, P. B., Sharma, A., Náray‐Fejes‐Tóth, A., Fejes‐Tóth, G., et al. (2014) · Nature Immunology · doi:10.1038/ni.2867 · Cited by 194 · see citing works

Localization of mTORC2 activity inside cells

Ebner, M., Sinkovics, B., Szczygieł, M., Ribeiro, D., & Yudushkin, I. (2017) · Journal of Cell Biology · doi:10.1083/jcb.201610060 · Cited by 181 · see citing works

Meet the neighbors: Mapping local protein interactomes by proximity‐dependent labeling with BioID

Varnaitė, R., & MacNeill, S. A. (2016) · PROTEOMICS · doi:10.1002/pmic.201600123 · Cited by 167 · see citing works

Activation of c‐Raf‐1 by Ras and Src through different mechanisms: activation in vivo and in vitro

Stokoe, D., & McCormick, F. P. (1997) · The EMBO Journal · doi:10.1093/emboj/16.9.2384 · Cited by 146 · see citing works

BioID identifies novel c-MYC interacting partners in cultured cells and xenograft tumors

Dingar, D., Kalkat, M., Chan, P.-K., Srikumar, T., Bailey, S. D., Tu, W. B., Coyaud, E., Ponzielli, R., Kolyar, M., Jurisica, I., et al. (2015) · Journal of Proteomics · doi:10.1016/j.jprot.2014.09.029 · Cited by 131 · see citing works

Transient Kinetic Studies on the Interaction of Ras and the Ras-Binding Domain of c-Raf-1 Reveal Rapid Equilibration of the Complex

Sydor, J. R., Engelhard, M., Wittinghofer, A., Goody, R. S., & Herrmann, C. (1998) · Biochemistry · doi:10.1021/bi980764f · Cited by 128 · see citing works

Human Sin1 contains Ras-binding and pleckstrin homology domains and suppresses Ras signalling

Schroder, W. A., Buck, M., Cloonan, N., Hancock, J. F., Suhrbier, A., Sculley, T. B., & Bushell, G. R. (2007) · Cellular Signalling · doi:10.1016/j.cellsig.2007.01.013 · Cited by 106 · see citing works

mTORC2 targets AGC kinases through Sin1-dependent recruitment

Cameron, A. J. M., Linch, M. D., Saurin, A. T., Escribano, C., & Parker, P. J. (2011) · Biochemical Journal · doi:10.1042/bj20110678 · Cited by 85 · see citing works

mTORC2 signaling drives the development and progression of pancreatic cancer

Driscoll, D. R., Karim, S., Sano, M., Gay, D., Jacob, W., Yu, J., Mizukami, Y., Gopinathan, A., Jodrell, D., Evans, T. R. J., et al. (2016) · Cancer Research · doi:10.1158/0008-5472.can-16-0810 · Cited by 72 · see citing works

CD98hc (SLC3A2) Loss Protects Against Ras-Driven Tumorigenesis by Modulating Integrin-Mediated Mechanotransduction

Estrach, S., Lee, S.-A., Boulter, E., Pisano, S., Errante, A., Tissot, F. S., Cailleteau, L., Pons, C., Ginsberg, M. H., & Féral, C. C. (2014) · Cancer Research · doi:10.1158/0008-5472.can-14-0579 · Cited by 71 · see citing works

Rab-Family GTPase Regulates TOR Complex 2 Signaling in Fission Yeast

Tatebe, H., Morigasaki, S., Murayama, S., Zeng, C. J. T., & Shiozaki, K. (2010) · Current Biology · doi:10.1016/j.cub.2010.10.026 · Cited by 66 · see citing works

Identification of the sites of interaction between c-Raf-1 and Ras-GTP.

Barnard, D., Diaz, B., Hettich, L., Chuang, E., Zhang, X., Avruch, J., & Marshall, M. S. (1995) · PubMed · Cited by 56 · see citing works

The small GTPases Ras and Rap1 bind to and control TORC2 activity

Khanna, A., Lotfi, P., Chavan, A. J., Montaño, N. M., Bolourani, P., Weeks, G., Shen, Z., Briggs, S. P., Pots, H., Haastert, P. J. M. V., et al. (2016) · Scientific Reports · doi:10.1038/srep25823 · Cited by 55 · see citing works

An Experimentally Derived Database of Candidate Ras-Interacting Proteins

Goldfinger, L. E., Ptak, C., Jeffery, E. D., Shabanowitz, J., Han, J., Haling, J. R., Sherman, N. E., Fox, J. W., Hunt, D. F., & Ginsberg, M. H. (2007) · Journal of Proteome Research · doi:10.1021/pr060630l · Cited by 47 · see citing works

KRAS Engages AGO2 to Enhance Cellular Transformation

Shankar, S., Pitchiaya, S., Malik, R., Kothari, V., Hosono, Y., Yocum, A. K., Gundlapalli, H., White, Y. N., Firestone, A. J., Cao, X., et al. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.01.034 · Cited by 45 · see citing works

Association of mSin1 with mTORC2 Ras and Akt reveals a crucial domain on mSin1 involved in Akt phosphorylation

Yao, C., Ortiz-Vega, S., Sun, Y.-Y., Chien, C., Chuang, J.-H., & Lin, Y. (2017) · Oncotarget · doi:10.18632/oncotarget.18818 · Cited by 22 · see citing works

Comparative proteomic analysis of compartmentalised Ras signalling

Hernández-Valladares, M., & Prior, I. (2015) · Scientific Reports · doi:10.1038/srep17307 · Cited by 11 · see citing works

mTOR at the nexus of nutrition, growth, ageing and disease

Liu, G. Y., & Sabatini, D. M. (2020) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-019-0199-y · Cited by 2,737 · see citing works

mTOR signaling pathway and mTOR inhibitors in cancer: progress and challenges

Zou, Z., Tao, T., Li, H., & Zhu, X. M. (2020) · Cell & Bioscience · doi:10.1186/s13578-020-00396-1 · Cited by 930 · see citing works

Regulation and metabolic functions of mTORC1 and mTORC2.

Szwed, A., Kim, E., & Jacinto, E. (2021) · Physiological Reviews · doi:10.1152/physrev.00026.2020 · Cited by 723 · see citing works

mTOR: Role in cancer, metastasis and drug resistance

Murugan, A. K. (2019) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2019.07.003 · Cited by 483 · see citing works

The metabolic landscape of RAS-driven cancers from biology to therapy

Mukhopadhyay, S., Vander Heiden, M. G., & McCormick, F. (2021) · Nature Cancer · doi:10.1038/s43018-021-00184-x · Cited by 315 · see citing works

Regulation of mTORC2 Signaling

Fu, W., & Hall, M. N. (2020) · Genes · doi:10.3390/genes11091045 · Cited by 213 · see citing works

The origins and genetic interactions of KRAS mutations are allele- and tissue-specific

Cook, J. H., Melloni, G. E. M., Gulhan, D. C., Park, P. J., & Haigis, K. M. (2021) · Nature Communications · doi:10.1038/s41467-021-22125-z · Cited by 208 · see citing works

Mass spectrometry‐based protein–protein interaction networks for the study of human diseases

Richards, A., Eckhardt, M., & Krogan, N. J. (2021) · Molecular Systems Biology · doi:10.15252/msb.20188792 · Cited by 199 · see citing works

Mapping the proximity interaction network of the Rho-family GTPases reveals signalling pathways and regulatory mechanisms

Bagci, H., Sriskandarajah, N., Robert, A., Boulais, J., Elkholi, I. E., Tran, V., Lin, Z., Thibault, M.-P., Dubé, N., Faubert, D., et al. (2019) · Nature Cell Biology · doi:10.1038/s41556-019-0438-7 · Cited by 163 · see citing works

RAS mutations in human cancers: Roles in precision medicine

Murugan, A. K., Grieco, M., & Tsuchida, N. (2019) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2019.06.007 · Cited by 146 · see citing works

The mTORC2 signaling network: targets and cross-talks

Ragupathi, A., Kim, C., & Jacinto, E. (2024) · Biochemical Journal · doi:10.1042/bcj20220325 · Cited by 113 · see citing works

PRMT5-mediated arginine methylation activates AKT kinase to govern tumorigenesis

Yin, S., Liu, L., Brobbey, C., Palanisamy, V., Ball, L. E., Olsen, S. K., Ostrowski, M. C., & Gan, W. (2021) · Nature Communications · doi:10.1038/s41467-021-23833-2 · Cited by 93 · see citing works

Dynamic regulation of RAS and RAS signaling

Kölch, W., Berta, D., & Rosta, E. (2023) · Biochemical Journal · doi:10.1042/bcj20220234 · Cited by 91 · see citing works

Interpretation of cancer mutations using a multiscale map of protein systems

Zheng, F., Kelly, M. R., Ramms, D. J., Heintschel, M. L., Tao, K., Tutuncuoglu, B., Lee, J. J., Ono, K., Foussard, H., Chen, M., et al. (2021) · Science · doi:10.1126/science.abf3067 · Cited by 81 · see citing works

Pleiotropic use of Statins as non-lipid-lowering drugs

Zhang, Q., Dong, J., & Yu, Z. Y. (2020) · International Journal of Biological Sciences · doi:10.7150/ijbs.42965 · Cited by 73 · see citing works

Splicing Factor SRSF1 Promotes Pancreatitis and KRASG12D-Mediated Pancreatic Cancer

Wan, L., Lin, K., Rahman, M. A., Ishigami, Y., Wang, Z., Jensen, M. A., Wilkinson, J. E., Park, Y., Tuveson, D. A., & Krainer, A. R. (2023) · Cancer Discovery · doi:10.1158/2159-8290.cd-22-1013 · Cited by 73 · see citing works

Expression of mTOR in normal and pathological conditions

Marques-Ramos, A., & Cervantes, R. (2023) · Molecular Cancer · doi:10.1186/s12943-023-01820-z · Cited by 72 · see citing works

In vivo interactome profiling by enzyme‐catalyzed proximity labeling

Xu, Y., Fan, X., & Hu, Y. (2021) · Cell & Bioscience · doi:10.1186/s13578-021-00542-3 · Cited by 59 · see citing works

The Ins and Outs of RAS Effector Complexes

Kiel, C., Matallanas, D., & Kölch, W. (2021) · Biomolecules · doi:10.3390/biom11020236 · Cited by 57 · see citing works

To Investigate the Occurrence and Development of Colorectal Cancer Based on the PI3K/AKT/mTOR Signaling Pathway

Zhong, J., Ding, S., Zhang, X., Di, W., Wang, X., Zhang, H., Chen, Y., Zhang, Y., & Hu, Y. (2023) · Frontiers in Bioscience-Landmark · doi:10.31083/j.fbl2802037 · Cited by 54 · see citing works

Ceramide Kinase Inhibition Drives Ferroptosis and Sensitivity to Cisplatin in Mutant KRAS Lung Cancer by Dysregulating VDAC-Mediated Mitochondria Function

Vu, N., Kim, M., Stephenson, D., MacKnight, H. P., & Chalfant, C. E. (2022) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-22-0085 · Cited by 51 · see citing works

Oncogenic KRAS is dependent upon an EFR3A-PI4KA signaling axis for potent tumorigenic activity

Adhikari, H., Kattan, W. E., Kumar, S., Zhou, P., Hancock, J. F., & Counter, C. M. (2021) · Nature Communications · doi:10.1038/s41467-021-25523-5 · Cited by 50 · see citing works

Disruption of the Scaffolding Function of mLST8 Selectively Inhibits mTORC2 Assembly and Function and Suppresses mTORC2-Dependent Tumor Growth In Vivo

Hwang, Y., Kim, L. C., Song, W., Edwards, D. N., Cook, R. S., & Chen, J. (2019) · Cancer Research · doi:10.1158/0008-5472.can-18-3658 · Cited by 50 · see citing works

The role of metabolic ecosystem in cancer progression — metabolic plasticity and mTOR hyperactivity in tumor tissues

Sebestyén, A. R., Dankó, T., Sztankovics, D., Moldvai, D., Raffay, R. E., Cervi, C., Krencz, I., Zsiros, V., Jeney, A., & Petővári, G. (2021) · Cancer and Metastasis Reviews · doi:10.1007/s10555-021-10006-2 · Cited by 46 · see citing works

The flipside of the TOR coin – TORC2 and plasma membrane homeostasis at a glance

Riggi, M., Kuśmider, B., & Loewith, R. (2020) · Journal of Cell Science · doi:10.1242/jcs.242040 · Cited by 46 · see citing works

Emerging Roles for Mammalian Target of Rapamycin (mTOR) Complexes in Bladder Cancer Progression and Therapy

Huan, J., Grivas, P. D., Birch, J., & Hansel, D. E. (2022) · Cancers · doi:10.3390/cancers14061555 · Cited by 43 · see citing works

Not all RAS mutations are equal: A detailed review of the functional diversity of RAS hot spot mutations

Burge, R. A., & Hobbs, G. A. (2022) · Advances in cancer research · doi:10.1016/bs.acr.2021.07.004 · Cited by 44 · see citing works

20(S)-Protopanaxatriol promotes the binding of P53 and DNA to regulate the antitumor network via multiomic analysis

Wang, Z., Wu, W., Guan, X., Guo, S., Li, C., Niu, R., Gao, J., Jiang, M., Bai, L., Leung, E. L., et al. (2020) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2020.01.017 · Cited by 41 · see citing works

Ras assemblies and signaling at the membrane

Nussinov, R., Tsai, C., & Jang, H. (2020) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2020.01.009 · Cited by 41 · see citing works

Methylglyoxal Scavengers Resensitize KRAS-Mutated Colorectal Tumors to Cetuximab

Bellier, J., Nokin, M.-J., Caprasse, M., Tiamiou, A., Blomme, A., Scheijen, J. L., Koopmansch, B., MacKay, G. M., Chiavarina, B., Costanza, B., et al. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.01.012 · Cited by 38 · see citing works

RAS interaction with Sin1 is dispensable for mTORC2 assembly and activity

Castel, P., Dharmaiah, S., Sale, M. J., Messing, S. A. J., Rizzuto, G. A., Cuevas-Navarro, A., Cheng, A. S., Trnka, M. J., Urisman, A., Esposito, D., et al. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2103261118 · Cited by 38 · see citing works

The Roles of Post-Translational Modifications on mTOR Signaling

Yin, S., Liu, L., & Gan, W. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22041784 · Cited by 38 · see citing works

Cross-talk between non-coding RNAs and PI3K/AKT/mTOR pathway in colorectal cancer

Moafian, Z., Maghrouni, A., Soltani, A., & Hashemy, S. I. (2021) · Molecular Biology Reports · doi:10.1007/s11033-021-06458-y · Cited by 37 · see citing works

TOR complex 2 is a master regulator of plasma membrane homeostasis

Thorner, J. W. (2022) · Biochemical Journal · doi:10.1042/bcj20220388 · Cited by 36 · see citing works

Glutamine Metabolism in Both the Oxidative and Reductive Directions Is Triggered in Shrimp Immune Cells (Hemocytes) at the WSSV Genome Replication Stage to Benefit Virus Replication

He, S.-T., Lee, D.-Y., Tung, C.-Y., Li, C.-Y., & Wang, H. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02102 · Cited by 36 · see citing works

Promotion of cancer cell stemness by Ras

Chippalkatti, R., & Abankwa, D. (2021) · Biochemical Society Transactions · doi:10.1042/bst20200964 · Cited by 36 · see citing works

mTOR Signaling Components in Tumor Mechanobiology

Gargalionis, A. N., Papavassiliou, K. A., Basdra, E. K., & Papavassiliou, A. G. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23031825 · Cited by 36 · see citing works

A novel MTORC2-AKT-ROS axis triggers mitofission and mitophagy-associated execution of colorectal cancer cells upon drug-induced activation of mutant KRAS

Iskandar, K. B., Foo, J., Liew, A. Q. X., Zhu, H., Raman, D., Hirpara, J. L., Leong, Y. Y., Babak, M. V., Kirsanova, A. A., Armand, A., et al. (2024) · Autophagy · doi:10.1080/15548627.2024.2307224 · Cited by 36 · see citing works

Signaling Pathways Involved in Nutrient Sensing Control in Cancer Stem Cells: An Overview

Robles‐Flores, M., Moreno-Londoño, Á. P., & Castañeda‐Patlán, M. C. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.627745 · Cited by 33 · see citing works

Alkaline intracellular pH (pHi) activates AMPK–mTORC2 signaling to promote cell survival during growth factor limitation

Kazyken, D., Lentz, S. I., & Fingar, D. C. (2021) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2021.101100 · Cited by 33 · see citing works

Ras, PI3K and mTORC2 – three's a crowd?

Smith, S. F., Collins, S. E., & Charest, P. G. (2020) · Journal of Cell Science · doi:10.1242/jcs.234930 · Cited by 32 · see citing works

Mechanosensitive mTORC2 independently coordinates leading and trailing edge polarity programs during neutrophil migration

Saha, S., Town, J. P., & Weiner, O. D. (2023) · Molecular Biology of the Cell · doi:10.1091/mbc.e22-05-0191 · Cited by 31 · see citing works

Functional and structural insights into RAS effector proteins

Mozzarelli, A. M., Simanshu, D. K., & Castel, P. (2024) · Molecular Cell · doi:10.1016/j.molcel.2024.06.027 · Cited by 31 · see citing works

DNA-PK promotes activation of the survival kinase AKT in response to DNA damage through an mTORC2-ECT2 pathway

Liu, L., Dai, X., Yin, S., Liu, P., Hill, E. G., Wei, W., & Gan, W. (2022) · Science Signaling · doi:10.1126/scisignal.abh2290 · Cited by 31 · see citing works

Oncogenic KRAS engages an RSK1/NF1 pathway to inhibit wild-type RAS signaling in pancreatic cancer

Cheng, D. K., Oni, T. E., Thalappillil, J. S., Park, Y., Ting, H.-C., Alagesan, B., Prasad, N. V., Addison, K., Rivera, K. D., Pappin, D. J., et al. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2016904118 · Cited by 30 · see citing works

Capturing the primordial Kras mutation initiating urethane carcinogenesis

Li, S., MacAlpine, D. M., & Counter, C. M. (2020) · Nature Communications · doi:10.1038/s41467-020-15660-8 · Cited by 28 · see citing works

Oncogenic RAS commandeers amino acid sensing machinery to aberrantly activate mTORC1 in multiple myeloma

Yang, Y., Bolomsky, A., Oellerich, T., Chen, P., Ceribelli, M., Häupl, B., Wright, G. W., Phelan, J. D., Huang, D. W., Lord, J. W., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-33142-x · Cited by 29 · see citing works

PTPN2 regulates the activation of KRAS and plays a critical role in proliferation and survival of KRAS-driven cancer cells

Huang, Z., Liu, M., Li, D., Tan, Y., Zhang, R., Xia, Z., Wang, P., Jiao, B., Liu, P., & Ren, R. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.ra119.011060 · Cited by 27 · see citing works

Mass Spectrometry-Based Protein Complex Profiling in Time and Space.

Zheng, J.-N., Chen, X., Yang, Y., Tan, C. S., & Tian, R.-J. (2020) · Analytical Chemistry · doi:10.1021/acs.analchem.0c04332 · Cited by 22 · see citing works

CD146 Regulates Growth Factor-Induced mTORC2 Activity Independent of the PI3K and mTORC1 Pathways

Xu, W., Hua, H., Chiu, Y.-H., Li, G., Zhi, H., Yu, Z., Ren, F., Luo, Y., & Cui, W. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.09.047 · Cited by 28 · see citing works

Signaling pathway dysregulation in breast cancer

Ryspayeva, D., Seyhan, A. A., MacDonald, W., Purcell, C., Roady, T. J., Ghandali, M., Verovkina, N., El‐Deiry, W. S., Taylor, M. S., & Graff, S. L. (2025) · Oncotarget · doi:10.18632/oncotarget.28701 · Cited by 30 · see citing works

Proximity labeling methods for proteomic analysis of membrane proteins

Zafra, F., & Piniella, D. (2022) · Journal of Proteomics · doi:10.1016/j.jprot.2022.104620 · Cited by 24 · see citing works

Silicon-rhodamine-enabled identification for near-infrared light controlled proximity labeling in vitro and in vivo

Wang, W., Guo, H., Yan, X., Pan, X., Wang, X., Rong, Y., Bai, Z., Zhang, L., Wu, Z., Zhao, X., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-63496-x · Cited by 27 · see citing works

Structural insights into Ras regulation by SIN1

Zheng, Y., Ding, L., Meng, X., Potter, M., Kearney, A. L., Zhang, J., Sun, J., James, D. E., Yang, G., & Zhou, C. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2119990119 · Cited by 24 · see citing works

Anti-leukemic effect of menthol, a peppermint compound, on induction of apoptosis and autophagy

Naksawat, M., Norkaew, C., Charoensedtasin, K., Roytrakul, S., & Tanyong, D. I. (2023) · PeerJ · doi:10.7717/peerj.15049 · Cited by 22 · see citing works

Mapping of mTOR drug targets: Featured platforms for anti-cancer drug discovery

Shams, R. S., Ito, Y., & Miyatake, H. (2021) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2021.108012 · Cited by 22 · see citing works

Regulation of GTPase function by autophosphorylation

Johnson, C. W., Seo, H., Terrell, E. M., Yang, M.-H., KleinJan, F., Gebregiworgis, T., Gasmi-Seabrook, G. M. C., Geffken, E. A., Lakhani, J., Song, K., et al. (2022) · Molecular Cell · doi:10.1016/j.molcel.2022.02.011 · Cited by 21 · see citing works

KRAS-Driven Tumorigenesis and KRAS-Driven Therapy in Pancreatic Adenocarcinoma

Than, M. T., O’Hara, M. H., Stanger, B. Z., & Reiss, K. A. (2024) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-23-0519 · Cited by 21 · see citing works

mTORC2 regulates ribonucleotide reductase to promote DNA replication and gemcitabine resistance in non-small cell lung cancer

Tian, L., Chen, C., Guo, Y., Zhang, F., Mi, J., Feng, Q., Lin, S., Xi, N., Tian, J., Yu, L., et al. (2021) · Neoplasia · doi:10.1016/j.neo.2021.05.007 · Cited by 19 · see citing works

mTOR Signaling in the Inner Ear as Potential Target to Treat Hearing Loss

Cortada, M., Levano, S., & Bodmer, D. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22126368 · Cited by 20 · see citing works

Reconstruction and analysis of a large-scale binary Ras-effector signaling network

Catozzi, S., Ternet, C., Gourrege, A., Wynne, K. J., Oliviero, G., & Kiel, C. (2022) · Cell Communication and Signaling · doi:10.1186/s12964-022-00823-5 · Cited by 19 · see citing works

Using Drosophila melanogaster to Dissect the Roles of the mTOR Signaling Pathway in Cell Growth

Frappaolo, A., & Giansanti, M. G. (2023) · Cells · doi:10.3390/cells12222622 · Cited by 19 · see citing works

Kallikrein 13 serves as a priming protease during infection by the human coronavirus HKU1

Milewska, A., Falkowski, K., Kulczycka, M., Bielecka, E., Naskalska, A., Mak, P., Lesner, A., Ochman, M., Urlik, M., Diamandis, E. P., et al. (2020) · Science Signaling · doi:10.1126/scisignal.aba9902 · Cited by 29 · see citing works

Afadin couples RAS GTPases to the polarity rheostat Scribble

Goudreault, M., Gagné, V., Jo, C. H., Singh, S., Killoran, R. C., Gingras, A., & Smith, M. J. (2022) · Nature Communications · doi:10.1038/s41467-022-32335-8 · Cited by 16 · see citing works

Flavonoids Targeting the mTOR Signaling Cascades in Cancer: A Potential Crosstalk in Anti‐Breast Cancer Therapy

Hussain, Y., Khan, H. Z., Alam, W., Aschner, M., Abdullah, Alsharif, K. F., & Saso, L. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/4831833 · Cited by 17 · see citing works

Expanding TOR Complex 2 Signaling: Emerging Regulators and New Connections

An, P., Xu, W., Luo, J., & Luo, Y. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.713806 · Cited by 15 · see citing works

Cystine Induced‐mTORC2 Activation through Promoting Sin1 Phosphorylation to Suppress Cancer Cell Ferroptosis

Wang, G., Chen, L., Qin, S., Zheng, Y., Xia, C., Yao, J., Wang, P., & Deng, L. (2022) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.202200186 · Cited by 15 · see citing works

RAS GTPase signalling to alternative effector pathways

Singh, S., & Smith, M. J. (2020) · Biochemical Society Transactions · doi:10.1042/bst20200506 · Cited by 15 · see citing works

The RUNX1-ETO target gene RASSF2 suppresses t(8;21) AML development and regulates Rac GTPase signaling

Stoner, S. A., Liu, K. T. H., Andrews, E. T., Liu, M., Arimoto, K., Yan, M., Davis, A. G., Weng, S., Dow, M. T., Su, X., et al. (2020) · Blood Cancer Journal · doi:10.1038/s41408-020-0282-9 · Cited by 15 · see citing works

RICTOR Affects Melanoma Tumorigenesis and Its Resistance to Targeted Therapy

Jebali, A., Battistella, M., Lebbé, C., & Dumaz, N. (2021) · Biomedicines · doi:10.3390/biomedicines9101498 · Cited by 14 · see citing works

Cell cycle control by the insulin-like growth factor signal: at the crossroad between cell growth and mitotic regulation

Scalia, P., Williams, S. J., Fujita‐Yamaguchi, Y., & Giordano, A. (2022) · Cell Cycle · doi:10.1080/15384101.2022.2108117 · Cited by 16 · see citing works

mTORC2 interactome and localization determine aggressiveness of high-grade glioma cells through association with gelsolin

Chantaravisoot, N., Wongkongkathep, P., Kalpongnukul, N., Pacharakullanon, N., Kaewsapsak, P., Ariyachet, C., Loo, J. A., Tamanoi, F., & Pisitkun, T. (2023) · Scientific Reports · doi:10.1038/s41598-023-33872-y · Cited by 14 · see citing works

Regulation of TORC2 Function and Localization in Yeast

Emmerstorfer‐Augustin, A., & Thorner, J. W. (2023) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev-cellbio-011723-030346 · Cited by 14 · see citing works

Unmasking the tumourigenic role of SIN1/MAPKAP1 in the mTOR complex 2

Ezine, E., Lebbé, C., & Dumaz, N. (2023) · Clinical and Translational Medicine · doi:10.1002/ctm2.1464 · Cited by 14 · see citing works

Acquired resistance to molecularly targeted therapies for cancer

Stubbs, N. M., Roady, T. J., Schwermann, M. P., Eteshola, E. O. U., MacDonald, W., Purcell, C., Ryspayeva, D., Verovkina, N., Tajiknia, V., Ghandali, M., et al. (2025) · Cancer Drug Resistance · doi:10.20517/cdr.2024.189 · Cited by 14 · see citing works

Glucose modulates IRF6 transcription factor dimerization to enable epidermal differentiation

Lopez-Pajares, V., Bhaduri, A., Zhao, Y., Gowrishankar, G., Donohue, L. K. H., Guo, M. G., Siprashvili, Z., Miao, W., Nguyen, D. T., Yang, X., et al. (2025) · Cell stem cell · doi:10.1016/j.stem.2025.02.017 · Cited by 20 · see citing works

mTORC2 Is Involved in the Induction of RSK Phosphorylation by Serum or Nutrient Starvation

Chou, P.-C., Rajput, S., Zhao, X., Patel, C., Albaciete, D., Oh, W. J., Queen, H., Patel, N., Su, B., Werlen, G., et al. (2020) · Cells · doi:10.3390/cells9071567 · Cited by 13 · see citing works

Drug targeting opportunities en route to Ras nanoclusters

Pavic, K., Chippalkatti, R., & Abankwa, D. (2022) · Advances in cancer research · doi:10.1016/bs.acr.2021.07.005 · Cited by 13 · see citing works

Proximal Protein Interaction Landscape of RAS Paralogs

Béganton, B., Coyaud, É., Laurent, E. M. N., Mangé, A., Jacquemetton, J., Romancer, M. L., Raught, B., & Solassol, J. (2020) · Cancers · doi:10.3390/cancers12113326 · Cited by 12 · see citing works

Proteomic Mapping of the Interactome of KRAS Mutants Identifies New Features of RAS Signalling Networks and the Mechanism of Action of Sotorasib

Nolan, A. A., Raso, C., Kölch, W., von Kriegsheim, A., Wynne, K. J., & Matallanas, D. (2023) · Cancers · doi:10.3390/cancers15164141 · Cited by 12 · see citing works

Defining bone fide effectors of RAS GTPases

Smith, M. J. (2023) · BioEssays · doi:10.1002/bies.202300088 · Cited by 12 · see citing works

Ras functional proximity proteomics establishes mTORC2 as new direct ras effector

Kovalski, J. R., Shanderson, R. L., & Khavari, P. A. (2019) · Oncotarget · doi:10.18632/oncotarget.27025 · Cited by 12 · see citing works

Claudin-1 is a mediator and therapeutic target in primary sclerosing cholangitis

Zompo, F. D., Crouchet, É., Ostyn, T., Nehme, Z., Messé, M., Jühling, F., Désert, R., Vieira, A. T., Moehlin, J., Nakib, D., et al. (2025) · Journal of Hepatology · doi:10.1016/j.jhep.2025.08.005 · Cited by 11 · see citing works

PHLPP2 is a pseudophosphatase that lost activity in the metazoan ancestor

Husremović, T., Meier, V., Piëch, L., Siess, K. M., Antonioli, S., Grishkovskaya, I., Kircheva, N., Angelova, S., Wenzl, K., Brandstätter, A., et al. (2025) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2417218122 · Cited by 11 · see citing works

Ras-mediated activation of mTORC2 promotes breast epithelial cell migration and invasion

Collins, S. E., Wiegand, M. E., Werner, A. N., Brown, I. N., Mundo, M. I., Swango, D. J., Mouneimne, G., & Charest, P. G. (2022) · Molecular Biology of the Cell · doi:10.1091/mbc.e22-06-0236 · Cited by 11 · see citing works

CRISPR-mediated reversion of oncogenic KRAS mutation results in increased proliferation and reveals independent roles of Ras and mTORC2 in the migration of A549 lung cancer cells

Werner, A. N., Kumar, A. I., & Charest, P. G. (2023) · Molecular Biology of the Cell · doi:10.1091/mbc.e23-05-0152 · Cited by 10 · see citing works

A Proteomic Approach Identifies Isoform-Specific and Nucleotide-Dependent RAS Interactions

Miller, S. P., Maio, G. E., Zhang, X., Soto, F. S. B., Zhu, J., Ramirez, S. Z., & Lin, H. (2022) · Molecular & Cellular Proteomics · doi:10.1016/j.mcpro.2022.100268 · Cited by 11 · see citing works

Oncogenic mutations of KRAS modulate its turnover by the CUL3/LZTR1 E3 ligase complex

Damianou, A., Liang, Z., Lassen, F. H., Vendrell, I., Vere, G., Hester, S., Charles, P. D., Pinto-Fernández, A., Santos, A., Fischer, R., et al. (2024) · Life Science Alliance · doi:10.26508/lsa.202302245 · Cited by 9 · see citing works

Kallikrein 13: a new player in coronaviral infectionsPreprint

Milewska, A., Falkowski, K., Kalińska, M., Bielecka, E., Naskalska, A., Mak, P., Lesner, A., Ochman, M., Urlik, M., Potempa, J., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.03.01.971499 · Cited by 9 · see citing works

RAS isoform specific activities are disrupted by disease associated mutations during cell differentiation

Chippalkatti, R., Parisi, B., Kouzi, F., Laurini, C., Fredj, N. B., & Abankwa, D. (2024) · European Journal of Cell Biology · doi:10.1016/j.ejcb.2024.151425 · Cited by 8 · see citing works

mTORC1 and 2 Adrenergic Regulation and Function in Brown Adipose Tissue

Festuccia, W. T. (2024) · Physiology · doi:10.1152/physiol.00023.2024 · Cited by 8 · see citing works

Role of FLCN Phosphorylation in Insulin‐Mediated mTORC1 Activation and Tumorigenesis

Wang, G., Chen, L., Lei, X., Qin, S., Geng, H., Zheng, Y., Xia, C., Yao, J., Meng, T., & Deng, L. (2023) · Advanced Science · doi:10.1002/advs.202206826 · Cited by 7 · see citing works

Regulation of RNA-binding proteins by small biomolecules

Miao, W., Porter, D. F., Lopez-Pajares, V., & Khavari, P. A. (2025) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-025-00914-4 · Cited by 7 · see citing works

Decoding the contextual duality of CD40 functions

Bandyopadhyay, S., Gurjar, D., Saha, B., & Bodhale, N. P. (2023) · Human Immunology · doi:10.1016/j.humimm.2023.08.142 · Cited by 7 · see citing works

MicroRNAs targeted mTOR as therapeutic agents to improve radiotherapy outcome

Taeb, S., Rostamzadeh, D., Amini, S. M., Rahmati, M., Eftekhari, M., Safari, A., & Najafi, M. (2024) · Cancer Cell International · doi:10.1186/s12935-024-03420-3 · Cited by 7 · see citing works

Prion-induced ferroptosis is facilitated by RAC3

Peng, H. F., Pfeiffer, S., Варинський, Б. О., Qiu, M., Srinark, C., Jin, X., Zhang, X., Williams, K., Groveman, B. R., Foliaki, S. T., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-60793-3 · Cited by 6 · see citing works

Identification of novel genes including NAV2 associated with isolated tall stature

Weiß, B., Ott, T., Vick, P., Lui, J. C. K., Roeth, R., Vogel, S., Waldmüller, S., Hoffmann, S., Baron, J., Wit, J. M., et al. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1258313 · Cited by 6 · see citing works

mTORC2: A neglected player in aging regulation

Xu, W., Chen, H., & Xiao, H. (2024) · Journal of Cellular Physiology · doi:10.1002/jcp.31363 · Cited by 6 · see citing works

Regulation of TORC2 function and localization by Rab5 GTPases inSaccharomyces cerevisiae

Locke, M. N., & Thorner, J. W. (2019) · Cell Cycle · doi:10.1080/15384101.2019.1616999 · Cited by 6 · see citing works

A cryptic microdeletion del(12)(p11.21p11.23) within an unbalanced translocation t(7;12)(q21.13;q23.1) implicates new candidate loci for intellectual disability and Kallmann syndrome

Ben‐Mahmoud, A., Kishikawa, S., Gupta, V. R., Leach, N. T., Shen, Y., Moldovan, O., Goel, H., Hopper, B., Ranguin, K., Gruchy, N., et al. (2023) · Scientific Reports · doi:10.1038/s41598-023-40037-4 · Cited by 5 · see citing works

Ras functional proximity proteomics establishes mTORC2 as new direct ras effector

Kovalski, J. R., Shanderson, R. L., & Khavari, P. A. (2019) · Oncotarget · doi:10.18632/oncotarget.27025 · Cited by 12 · see citing works

Using BioID to Characterize the RAS Interactome

Adhikari, H., & Counter, C. M. (2021) · Methods in molecular biology · doi:10.1007/978-1-0716-1190-6_16 · Cited by 4 · see citing works

The Functional Proximal Proteome of Oncogenic Ras Includes mTORC2. Kovalski et al.

Khavari, P. A. (2018) · Data Archiving and Networked Services (DANS) · doi:10.17632/kzxnrmh7fc

Proximal Protein Interaction Landscape of RIT2 Neuronal GTPase

White, S. S., Liu, H., Campos, A. R., & Andres, D. (2021) · The FASEB Journal · doi:10.1096/fasebj.2021.35.s1.05423

Direct physical interaction of active Ras with mSIN1 regulates mTORC2 signaling

Lone, M. D., Miyan, J., Asif, M., Malik, S. A., Dubey, P., Singh, V., Singh, K., Mitra, K., Pandey, D., Haq, W., et al. (2019) · BMC Cancer · doi:10.1186/s12885-019-6422-6 · Cited by 25 · see citing works